The largest community of pharma leaders

DeciBio Spins off Technology Products as a Subsidiary Entity, DeciBio Analytics

LOS ANGELES–()–Last year, DeciBio Consulting announced the formation of DeciBio Analytics, a subsidiary entity that develops market intelligence informatics tools and technologies and informatics-oriented consulting work. With the mission to accelerate commercialization of innovation in the precision medicine space by building novel and propriety solutions that empower our clients, DeciBio Analytics will continue to develop both open platforms and proprietary tools that enable clients to better harness and analyze the wealth of information continuously generated about the precision medicine industry.

A wholly-owned subsidiary of DeciBio Consulting, DeciBio Analytics is led by Pranay Madan, who initiated the entity’s original efforts and is responsible for developing and executing DeciBio Analytics’ product strategy. Pranay Madan received a bachelor’s in Bio-technology Engineering from Panjab University and a master’s in Business & Science from Keck Graduate Institute. He joined DeciBio in 2014 and has since deployed multiple advanced analytical platforms across major Life Science and Healthcare clients. More information about DeciBio Analytics can be found at its website: https://www.decibio-analytics.com/

About DeciBio

DeciBio Consulting is a boutique strategy consulting and market research firm focusing on the life science industry. DeciBio’s mission is to provide the market intelligence and strategic insights that drive disruption and innovation in precision medicine.

Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 healthcare corporations. DeciBio addresses business solutions in the areas of market landscape analysis, product development, voice-of-customer feedback, new product launches, technology assessment, competitive landscape analysis, business case strategy, and commercial due diligence.

Source

Recent Articles

Javelin Biotech Aims to Develop Industry-Leading “Organ-on-a-Chip” Predictive Pharmacokinetics Platform in Collaboration with Pfizer Inc.

WOBURN, Mass.--(BUSINESS WIRE)--Javelin Biotech today announces a 3-year collaboration with Pfizer...

TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate

DENVER & CHICAGO--(BUSINESS WIRE)-- #TollLikeReceptor--TriSalus Life Sciences announces its therapeutic clinical...

Cortexyme Announces GAIN Trial of Atuzaginstat in Alzheimer’s Disease Has Exceeded Study Enrollment Target of 570 Patients

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX) today announced that...

VBI Vaccines to Present at Upcoming Scientific Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $VBIV--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage...

Anokion Announces FDA Clearance of IND Application for ANK-700 for the Treatment of Multiple Sclerosis

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--Anokion Announces FDA Clearance of IND...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.